ENTITY
Grifols SA

Grifols SA (GRF SM)

95
Analysis
Health Care • Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullish•Grifols
•18 Jul 2024 19:44

Liquid Universe of European Ordinary and Preferred Shares: July‘24 Report

Since mid-June, share-price spreads have generally tightened across our European liquid universe of ordinary and preferred shares (13 have...

Share
•14 Jul 2024 07:00

Last Week in Event SPACE: Toyota, Asia Cement, Hanwha Corp, Kokusai Electric, Keisei Electric

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
596 Views
Share
bullish•Grifols SA
•08 Jul 2024 16:47

(Desperate) Takeover Bid in the Making

Grifols' founding families and Brookfield ask the Board for the necessary information to evaluate an offer for 100% of Grifols SA (GRF SM). The...

Share
bullish•Grifols SA
•01 Jul 2024 00:17

Another Debt Downgrade

​Moody's downgrades Grifols' rating due to high leverage and opaque governance. For risk-tolerant investors, the current low share price could...

Share
bullish•Grifols SA
•22 Jun 2024 05:04•Syndicated

Grifols S A (GRF/P SM) - Friday, Mar 22, 2024

Gotham City Research's short report on Grifols is seen as misguided, creating a buying opportunity for investors. Grifols is still viewed as a...

Share
x